Company / Financials
Minerva Neurosciences, Inc. Financials
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$0
FY2024
Net Income
$1.4M
FY2024 · +104.5% YoY
Profit Margin
-
FY2024 · net income / revenue
ROE
-
FY2024 · return on equity
Total Assets
$37.1M
FY2024
Total Debt
-
FY2024
Equity
-$25.7M
FY2024
ROA
3.9%
FY2024 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$0Net Income HistoryProfit after all expenses and taxes$1.4M+104.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$21.8M+13.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$9.9M-6.0% YoYR&D Expense HistoryResearch and development spending$11.9M-18.8% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$4.61+23.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$4.61+23.3% YoYShares Outstanding HistoryWeighted average diluted shares outstanding7.0M+31.0% YoYTotal Assets HistoryTotal value of all assets owned$37.1M-34.7% YoY